Dextran from Leuconostoc spp. (DXT-40, Mr ~40 kDa), glycidyl methacrylate (GMA) (97%), dimethyl sulfoxide (DMSO) (98%), 3-mercaptopropionic acid (≥99%), 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM·HCl) (96%) and 2,2′-
OH, Guard-Aquagel-OH columns and a differential refractive index (RI) detector. 0.3 M NaNO 3 , 0.01 M NaH 2 PO 4 , pH 7 was used as eluent at a flow rate of 1 mL/min. The system was calibrated using polyethylene oxide (PEO) standards.
Transmission electron microscopy (TEM):
TEM analyses were performed in a TECNAI G2 20 TWIN microscope (FEI, Eindhoven, The Netherlands), operating at an accelerating voltage of 200 KeV in a bright-field image mode. One drop of the sample dispersion in water (~3 μL, 0.035 mg/mL) was deposited on a carbon film supported on a copper grid (300 mesh), hydrophilized by a glow discharge process just prior to use. After staining for 20 seconds with a uranyl acetate aqueous solution (1% w/v), the sample was rotated at high speed in order to dry at room temperature quickly by spinning process. Numberaverage diameter was calculated by ImageJ platform analysis using a Gaussian curve fitting after counting about 300 nanoparticles.
Nuclear magnetic resonance ( 1 H NMR and DOSY NMR):
NMR spectra were recorded on a Bruker AVANCE III spectrometer at 500 MHz and 25 ºC. Chemical shifts (δ) are given in ppm relative to the residual signal of the solvent. Splitting patterns: b, broad; s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet.
Diffusion Coefficient calculations:
Taylor dispersion analysis (TDA) studies were performed on a Viscosizer-TD using fused silica capillaries. The mobile phase was water and the solutes were monitored by UV absorbance (UV wavelength filter 214 nm) at two fixed windows. Diffusion coefficient experiments were run at 25 ºC and 140 mbar.
Fourier transform infrared (FTIR) spectra were registered at room temperature in a Jasco FT/IR 4100 spectrophotometer, using a Gladi ATR accessory.
Synthesis of the dextran methacrylated precursor polymer [DXT-MA (DS ~52%)]
Dextran methacrylated polymer (DXT-MA) was synthesized following a slightly modified published procedure [1S] . Dextran (DXT-40, 1g, 6.2 mmol) was dissolved in 30 mL of dimethyl sulfoxide (DMSO) under a nitrogen atmosphere, to this solution 200 mg of 4-(N,N-dimethylamino)pyridine (DMAP, 1.6 mmol) was added. 
Preparation of dextran-based single-chain polymer nanoparticles (DXT-SCPN)
In a standard procedure, 0.38 mL of a previously prepared 0.15 M solution (2 mL, MeOH/PBS, 1:1, v/v, pH= 9.5) of cross-linker DODT (0.06 mmol, 49 L) was added dropwise using a syringe pump (0.05 mL/h) over a 0.02 M solution of DXT-MA (DS=52%) (100 mg, 0.025 mmol, 13 mL PBS, pH= 9.5) during 8 h at room temperature and under constant stirring. After addition, the reaction was maintained stirred at room temperature for 12 h. Then, the disappearance of the -SH groups from the 
Functionalization of DXT-SCPN with 3-mercaptopropionic acid (DXT-SCPN-F)
One batch synthesis of the functionalized DXT-SCPN-F was achieved by adding slowly 2 mL of an aqueous solution of 3-mercapto propionic acid (61.4 L, 7.5 mol, pH= 9.5) to the reaction flask in the previously reported synthesis of the DXT-SCPN. The reaction was stirred for 24 h and the excess acid was removed by dialysis against distilled water (MWCO 3500Da) until reaching deionized water conductivity values < 1S (5 days, refreshing with 4L of deionized water twice per day). The resulting aqueous solution was freeze-dried to obtain nanoparticles as a white solid. Yield >90%. 1 H NMR (500 MHz, 
Comparison of FT-IR spectra
Figure S10: Full FT-IR (up) and insight (bottom) of dextran methacrylated precursor polymer (DXT-MA, in red), the corresponding single-chain nanoparticles (DXT-SCPN, in green), the MPA-functionalized DXT-SCPN (DXT-SCPN-F, in blue) and the polymer control system which consists of MPA-functionalized DXT-MA (DXT-MA-F, in violet).
Cytotoxicity
In vitro cytotoxicity studies were carried out with the MTS assay, after 48 h of exposure to increasing concentrations of nanoparticle ranging from 6.25 to 50 μg/mL.
Cell viability analysis showed that under the conditions of this study none of the tested concentrations caused a significant decrease in cell viability when compared with none treated cells ( Figure S7) . Moreover, morphological analysis of Hela cells showed a typical epithelial adherent morphology.
Cell culture: HeLa cells were cultured in medium containing EMEM (Gibco), 10% fetal bovine serum (Lonza), 1X non-essential amino acid (NEAA) (Sigma), 1% penicillin/ streptomycin (Sigma), 2 mM L glutamine (Sigma). Trypsin (0.25%)/EDTA were used to harvest the cells at 80% confluence. Cell cultures were maintained at 37 ºC in an incubator with 95% humidity and 5% of CO 2 . The cultures were replenished with fresh medium at 37 ºC twice a week. percentage) was calculated as the ratio between the amount of radioactivity in the filter and the total amount of radioactivity in all fractions. Finally, the nanoparticles were suspended in 0.2 M sodium acetate buffer solution (pH 4.2). Radiochemical yield was calculated as the ratio between the amount of radioactivity in the resuspended fraction and the starting amount of radioactivity.
Radiochemical stability of SCPNs: Radiolabelled nanoparticles prepared as described above were incubated in sodium acetate buffered solution at 37 °C using a digital block heater. At different time points (1, 3, 24, 48, 72 and 144 h) samples were withdrawn and the amount of radioactivity was measured. The 67 Ga-radiolabelled SCPNs were filtered, washed twice with ultrapure water, and the amount of radioactivity in the filter and the filtrate/washings was measured. The radiochemical stability was calculated as the percentage of radioactivity in the pellet with respect to the total amount of radioactivity (pellet + filtrate + washings).
Animal studies: Animals were maintained and handled in accordance with the Guidelines for Accommodation and Care of Animals (European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes). All animal procedures were performed in accordance with the Spanish policy for animal protection radioactivity around 1.85 MBq). Immediately after, rats were submitted to in vivo imaging studies.
In vivo imaging studies: Immediately after administration of the radiolabeled SCPNs, and without recovering from sedation, animals were positioned in an eXplore speCZT CT preclinical imaging system (GE Healthcare, USA) to perform in vivo studies. Body temperature was maintained with a homeothermic blanket control unit (Bruker BioSpin GmbH, Karlsruhe, Germany) to prevent hypothermia, and SPECT scans were acquired for 30 min. After the SPECT scan, a CT acquisition was performed to provide anatomical information of each animal. The SPECT images were reconstructed using a orderedsubset expectation maximization (OSEM) iterative algorithm (3 iterations/3 subsets, 
